BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18384840)

  • 21. Quantitative distribution of a panel of circulating mRNA in preeclampsia versus controls.
    Farina A; Sekizawa A; Purwosunu Y; Rizzo N; Banzola I; Concu M; Morano D; Giommi F; Bevini M; Mabrook M; Carinci P; Okai T
    Prenat Diagn; 2006 Dec; 26(12):1115-20. PubMed ID: 16952198
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alternations of maternal and cord plasma hemostasis in preeclampsia before and after delivery.
    Xiong Y; Zhou SF; Zhou R; Yang D; Xu ZF; Lou YT; Guo QS; Hu R; Peng T; Ma D; Li XT
    Hypertens Pregnancy; 2011; 30(3):347-58. PubMed ID: 21174589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Newborns of pre-eclamptic women: a biochemical difference present in utero.
    Ophir E; Dourleshter G; Hirsh Y; Fait V; German L; Bornstein J
    Acta Obstet Gynecol Scand; 2006; 85(10):1172-8. PubMed ID: 17068675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hemostatic system parameters of placental extracts in normal pregnancy and severe preeclampsia].
    López-Ramírez Y; Carvajal Z; Arocha-Piñango CL
    Invest Clin; 2006 Sep; 47(3):233-40. PubMed ID: 17672283
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High concentrations of plasminogen activator inhibitor-1 in lungs of preterm infants with respiratory distress syndrome.
    Cederqvist K; Sirén V; Petäjä J; Vaheri A; Haglund C; Andersson S
    Pediatrics; 2006 Apr; 117(4):1226-34. PubMed ID: 16585319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study on thrombomodulin and plasminogen activator inhibitor type-1 in patients of pregnancy induced hypertension].
    Ma S; Bai C; Bian X
    Zhonghua Fu Chan Ke Za Zhi; 1999 Dec; 34(12):712-4. PubMed ID: 11479955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered endothelial function following the Fontan procedure.
    Binotto MA; Maeda NY; Lopes AA
    Cardiol Young; 2008 Feb; 18(1):70-4. PubMed ID: 18093358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of maternal and umbilical serum TNFalpha levels in preeclamptic pregnancies in the intrauterine normal and growth-restricted fetus.
    Laskowska M; Leszczyńska-Gorzelak B; Laskowska K; Oleszczuk J
    J Matern Fetal Neonatal Med; 2006 Jun; 19(6):347-51. PubMed ID: 16801311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased placental antifibrinolytic potential and fibrin deposits in pregnancy-induced hypertension and preeclampsia.
    Kanfer A; Bruch JF; Nguyen G; He CJ; Delarue F; Flahault A; Nessmann C; Uzan S
    Lab Invest; 1996 Jan; 74(1):253-8. PubMed ID: 8569189
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uteroplacental hemostasis in intrauterine fetal growth retardation.
    Sheppard BL; Bonnar J
    Semin Thromb Hemost; 1999; 25(5):443-6. PubMed ID: 10625199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Changes in fibrinolysis-associated parameters in HELLP syndrome].
    Kolben M; Lopens A; Schmitt M; Schneider KT; Graeff H
    Geburtshilfe Frauenheilkd; 1994 May; 54(5):257-61. PubMed ID: 8050684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endothelial damage and blood coagulation activation in preeclampsia].
    Stella A; Babbo GL; Grella PV
    Minerva Ginecol; 1998 Nov; 50(11):463-8. PubMed ID: 9882986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal expression of type 1 plasminogen activator inhibitor and tissue factor in severe preeclampsia.
    Estellés A; Gilabert J; Grancha S; Yamamoto K; Thinnes T; España F; Aznar J; Loskutoff DJ
    Thromb Haemost; 1998 Mar; 79(3):500-8. PubMed ID: 9580327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coagulation and fibrinolysis in preeclampsia and neonates.
    Tanjung MT; Siddik HD; Hariman H; Koh SC
    Clin Appl Thromb Hemost; 2005 Oct; 11(4):467-73. PubMed ID: 16244774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex congenital malformations and the impact of the plasminogen activator system and beta-hCG in amniotic fluid.
    Verkleij-Hagoort AC; Ursem NT; Hop WC; Geurts-Moespot A; Steegers EA; Sweep FC; Steegers-Theunissen RP
    Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):47-52. PubMed ID: 17141398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of maternal serum high-sensitive C-reactive protein levels with biochemical and clinical parameters in preeclampsia.
    Kumru S; Godekmerdan A; Kutlu S; Ozcan Z
    Eur J Obstet Gynecol Reprod Biol; 2006 Feb; 124(2):164-7. PubMed ID: 16054746
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced PAI-1 levels from early second trimester and during labour and plasminogen activators in normal pregnancy.
    Koh SC; Anandakumar C; Biswas A; Fong YF
    Thromb Haemost; 2002 Jan; 87(1):175-6. PubMed ID: 11858184
    [No Abstract]   [Full Text] [Related]  

  • 39. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.
    Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K
    Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced third-trimester levels of soluble human leukocyte antigen G protein in severe preeclampsia.
    Hackmon R; Koifman A; Hyodo H; Glickman H; Sheiner E; Geraghty DE
    Am J Obstet Gynecol; 2007 Sep; 197(3):255.e1-5. PubMed ID: 17826409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.